CClinicalTrials.gg
CompletedNCT06887868Updated Mar 24, 2025

Immediate Effect of Mobilization with Movement on Squat Self-reported Functional Ability, Pain Intensity, and Pain-free Range of Motion in People with Knee Osteoarthritis

An interventional study of Mobilization with movement and Sham mobilization with movement in Knee Osteoarthritis (Knee OA), sponsored by Escola Superior de Tecnologia da Saúde do Porto. Completed at 1 site in Portugal. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by Escola Superior de Tecnologia da Saúde do Porto · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 10 months after the study started (first participant enrolled May 2022, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

Mobilization with movement (MWM) appears to reduce pain, improve knee range of motion, and enhance physical functioning in individuals with knee osteoarthritis (KOA). However, it remains unclear whether the severity grading of structural damage in KOA affects its effects. This study aims to analyze the immediate effect of MWM on squat self-reported functional ability, pain intensity, and pain-free range of motion in people with KOA, and to verify it its effect is influenced by the severity grading of structural damage.

02

Conditions studied

  • Knee Osteoarthritis (Knee OA)

Keywords

  • Knee Osteoarthritis
  • manual therapy
  • mobilization with movement
  • functional status
  • Mulligan concept
  • neurophysiological effect
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 40 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Escola Superior de Tecnologia da Saúde do Porto is the lead sponsor of 37 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • male or female;
  • aged over 45 years;
  • clinically diagnosed with symptomatic unilateral KOA, classified as grade 1-3 according to the Kellgren and Lawrence system;
  • fulfilled the classification criteria of the American College of Rheumatology for KOA;
  • reported frequent episodes of pain in the knee joint during sit-to-stand movements for at least 3 months.

Exclusion criteria

Exclusion Criteria:

  • had KOA secondary to rheumatoid arthritis and other inflammatory and autoimmune conditions;
  • reported lumbar pain radiating to the knee or lumbar pain as the primary complaint;
  • had a history of knee or lower limb surgery;
  • had a systemic or local infection;
  • had received an intra-articular corticosteroid or hyaluronic acid injection within the past 6 months;
  • reported current or past (within 4 weeks) oral corticosteroid use;
  • had any condition in the lower limbs that would prevent performing the deep squat test;
  • had clinical conditions in which manual therapy is generally contraindicated (such as fracture, osteoporosis, instability, infectious arthritis, tumors, joint ankylosis, acute inflammatory disorders, or lack of a diagnosed joint lesion).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    MWM

    The intervention group received the MWM technique, which involved the manual application of a sustained translational or rotational glide force, either medial or lateral, on the tibia, while an active partial weight-bearing lunge movement was performed. All glide forces were tested in a randomly pre-established order, and the most effective force for symptom relief and improvement in knee range of motion was selected for the intervention.

    Procedure: Mobilization with movement

  • Sham comparator
    Sham MWM

    In the sham group, the participants underwent a similar procedure to those in the intervention group. The physiotherapist mimicked the pain-reducing glide direction without applying glide force while the participants performed the active lunge movement. To achieve this, the physiotherapist's hands lightly touched the knee skin, with one hand on the tibia and the other on the femur over the joint surfaces. The volume of the sham MWM technique was identical to that of the MWM technique administered to the intervention group.

    Procedure: Sham mobilization with movement

Interventions

  • ProcedureMobilization with movement

    Manual application of a sustained translational or rotational glide force, either medial or lateral, on the tibia, while an active partial weight-bearing lunge movement was performed.

    Also known as: MWM, Mulligan concept

  • ProcedureSham mobilization with movement

    The physiotherapist mimicked the pain-reducing glide direction without applying glide force while the participants performed the active lunge movement. To achieve this, the physiotherapist's hands lightly touched the knee skin, with one hand on the tibia and the other on the femur over the joint surfaces.

06

What researchers measure

Primary outcomes

  1. Functional ability

    The Patient-Specific Functional Scale was used to assess self-reported functional ability. This scale is a self-reported, valid, and responsive outcome measure used to quantify activity limitations and evaluate functional outcomes for individuals with musculoskeletal conditions. Participants rated their current level of ability to performing the deep squat test on an 11-point scale at a level experienced prior to injury or change in functional status, where "0" represents "unable to perform" and "10" represents "able to perform at prior level.

    Time frame: Baseline

  2. Knee Pain

    The Numeric Pain Rating Scale is a self-reported, valid, and responsive outcome measure that was used in this study to quantify pain intensity. Participants rated their current pain intensity related to performing the deep squat test on a scale divided into eleven equal parts, numbered consecutively from 0 to 10, where "0" represents "No Pain" and "10" represents "Worst Possible Pain" (the most intense pain imaginable).

    Time frame: Baseline

  3. Pain free Range of Motion (ROM)

    This test has been advocated as a useful method for evaluating knee pain and function. Participants began the deep squat test by standing with their feet flat on the floor, approximately shoulder-width apart, aligned in the sagittal plane, and their hands placed on their pelvis (adapted from the original test description). They were then instructed to squat (buttocks towards the heels) as low as possible until the onset of pain, while maintaining an upright torso, avoiding asymmetric weight shift, and keeping their heels and toes in position. Before the test, participants viewed a demonstration video to optimize their understanding of the procedures. Additionally, they were given the opportunity to perform a practice trial of the deep squat test at a pain-free range of motion.

    Time frame: Baseline

07

Study locations

1 site
  • E2S | P.PORTO - Escola Superior de Saúde do Politécnico do Porto
    Porto, 4200-072, Portugal
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06887868
Lead sponsor
Escola Superior de Tecnologia da Saúde do Porto
Responsible party
Daniela Ferreira Carneiro (MSc, Escola Superior de Tecnologia da Saúde do Porto) — Principal investigator
First posted
Mar 20, 2025
Start date
May 1, 2022
Primary completion
Jun 30, 2023
Completion
Jul 31, 2023
Last update
Mar 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion